JPRN-UMIN000048637招募中未知
Efficacy and safety study of PAXMAN and HairRepro MEDI Alpha for Chemotherapy Induced Alopecia for breast cancer - PAXMAN and HairRepro MEDI Alpha study
Department of Surgery and Science, Faculty of Medicine,Academic Assembly, University of Toyama0 个研究点目标入组 27 人开始时间: 2022年8月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 100years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Patients with active multiple cancers 2) Patients with serious concomitant diseases (such as hepatic, renal, cardiac, hematological, or metabolic diseases) or psychiatric disorders 3) Patients who have been taking concomitantly banned drugs or study drugs within 4 weeks prior to the start of the study. 4) Patients with a history of allergy to Clozapine 5) Patients with eczema or other skin diseases on the head
研究者
相似试验
尚未招募
不适用
Hairsteticsâ?¢ Anchoring System and Hair Extensions with female hair lossCTRI/2017/05/008472Hairstetics Ltd10
尚未招募
3 期
A clinical trial to study the safety and effectiveness of Hairsteticsâ?? Hair Implant in subjects having problem of Hair LossCTRI/2014/04/004533Hairstetics Ltd36
尚未招募
Unknown
Checking of safety and efficacy of productCTRI/2024/04/065569KAYA LIMITED
已完成
Unknown
The effectiveness and safety evaluation of hair growth promotor containing teak leaf extractISRCTN24541842ational Research Council of Thailand90
尚未招募
Unknown
Effect of product on hair thickness and hair fallCTRI/2024/08/072061Patanjali Ayurved Limited